Literature DB >> 26931467

Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome.

Sungkook Hong1, Ping Hu1, Juliana Marino2, Sophia B Hufnagel3, Robert J Hopkin3, Alma Toromanović4, Antonio Richieri-Costa2, Lucilene A Ribeiro-Bicudo2, Paul Kruszka1, Erich Roessler1, Maximilian Muenke5.   

Abstract

Mutations in FGFR1 have recently been associated with Hartsfield syndrome, a clinically distinct syndromic form of holoprosencephaly (HPE) with ectrodactly, which frequently includes combinations of craniofacial, limb and brain abnormalities not typical for classical HPE. Unrelated clinical conditions generally without craniofacial or multi-system malformations include Kallmann syndrome and idiopathic hypogonadotropic hypogonadism. FGFR1 is a principal cause for these less severe diseases as well. Here we demonstrate that of the nine FGFR1 mutations recently detected in our screen of over 200 HPE probands by next generation sequencing, only five distinct mutations in the kinase domain behave as dominant-negative mutations in zebrafish over-expression assays. Three FGFR1 mutations seen in HPE probands behave identical to wild-type FGFR1 in rescue assays, including one apparent de novo variation. Interestingly, in one HPE family, a deleterious FGFR1 allele was transmitted from one parent and a loss-of-function allele in FGF8 from the other parent to both affected daughters. This family is one of the clearest examples to date of gene:gene synergistic interactions causing HPE in humans. Published by Oxford University Press 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26931467      PMCID: PMC5062582          DOI: 10.1093/hmg/ddw064

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Characterization of embryonic globin genes of the zebrafish.

Authors:  Alison Brownlie; Candace Hersey; Andrew C Oates; Barry H Paw; Arnold M Falick; H Ewa Witkowska; Jonathan Flint; Doug Higgs; Jason Jessen; Nathan Bahary; Hao Zhu; Shuo Lin; Leonard Zon
Journal:  Dev Biol       Date:  2003-03-01       Impact factor: 3.582

2.  Novel interstitial deletion of 10q24.3-25.1 associated with multiple congenital anomalies including lobar holoprosencephaly, cleft lip and palate, and hypoplastic kidneys.

Authors:  Iskra T Peltekova; Julie Hurteau-Millar; Christine M Armour
Journal:  Am J Med Genet A       Date:  2014-09-24       Impact factor: 2.802

3.  Childhood growth of females with Kallmann syndrome and FGFR1 mutations.

Authors:  Matti Hero; Eeva-Maria Laitinen; Tero Varimo; Kirsi Vaaralahti; Johanna Tommiska; Taneli Raivio
Journal:  Clin Endocrinol (Oxf)       Date:  2014-06-25       Impact factor: 3.478

4.  Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.

Authors:  Catherine Dodé; Jacqueline Levilliers; Jean-Michel Dupont; Anne De Paepe; Nathalie Le Dû; Nadia Soussi-Yanicostas; Roney S Coimbra; Sedigheh Delmaghani; Sylvie Compain-Nouaille; Françoise Baverel; Christophe Pêcheux; Dominique Le Tessier; Corinne Cruaud; Marc Delpech; Frank Speleman; Stefan Vermeulen; Andrea Amalfitano; Yvan Bachelot; Philippe Bouchard; Sylvie Cabrol; Jean-Claude Carel; Henriette Delemarre-van de Waal; Barbara Goulet-Salmon; Marie-Laure Kottler; Odile Richard; Franco Sanchez-Franco; Robert Saura; Jacques Young; Christine Petit; Jean-Pierre Hardelin
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

5.  Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis.

Authors:  Catherine Dodé; Corinne Fouveaut; Geert Mortier; Sandra Janssens; Jérôme Bertherat; Jacques Mahoudeau; Marie-Laure Kottler; Christine Chabrolle; Antoine Gancel; Inge François; Koen Devriendt; Slawomir Wolczynski; Michel Pugeat; Alfons Pineiro-Garcia; Arnaud Murat; Philippe Bouchard; Jacques Young; Marc Delpech; Jean-Pierre Hardelin
Journal:  Hum Mutat       Date:  2007-01       Impact factor: 4.878

6.  Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.

Authors:  Nelly Pitteloud; Richard Quinton; Simon Pearce; Taneli Raivio; James Acierno; Andrew Dwyer; Lacey Plummer; Virginia Hughes; Stephanie Seminara; Yu-Zhu Cheng; Wei-Ping Li; Gavin Maccoll; Anna V Eliseenkova; Shaun K Olsen; Omar A Ibrahimi; Frances J Hayes; Paul Boepple; Janet E Hall; Pierre Bouloux; Moosa Mohammadi; William Crowley
Journal:  J Clin Invest       Date:  2007-01-18       Impact factor: 14.808

Review 7.  The genetics of early telencephalon patterning: some assembly required.

Authors:  Jean M Hébert; Gord Fishell
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

8.  Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism.

Authors:  Taneli Raivio; Yisrael Sidis; Lacey Plummer; Huaibin Chen; Jinghong Ma; Abir Mukherjee; Elka Jacobson-Dickman; Richard Quinton; Guy Van Vliet; Helene Lavoie; Virginia A Hughes; Andrew Dwyer; Frances J Hayes; Shuyun Xu; Susan Sparks; Ursula B Kaiser; Moosa Mohammadi; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

9.  Duplication of fgfr1 permits Fgf signaling to serve as a target for selection during domestication.

Authors:  Nicolas Rohner; Miklós Bercsényi; László Orbán; Maria E Kolanczyk; Dirk Linke; Michael Brand; Christiane Nüsslein-Volhard; Matthew P Harris
Journal:  Curr Biol       Date:  2009-09-03       Impact factor: 10.834

Review 10.  Initiation to end point: the multiple roles of fibroblast growth factors in neural development.

Authors:  Ivor Mason
Journal:  Nat Rev Neurosci       Date:  2007-08       Impact factor: 34.870

View more
  13 in total

1.  A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway.

Authors:  Pietro Palumbo; Antonio Petracca; Roberto Maggi; Tommaso Biagini; Grazia Nardella; Michele Carmine Sacco; Elia Di Schiavi; Massimo Carella; Lucia Micale; Marco Castori
Journal:  Eur J Hum Genet       Date:  2019-02-20       Impact factor: 4.246

2.  The Use of Variant Maps to Explore Domain-Specific Mutations of FGFR1.

Authors:  L A Lansdon; H V Bernabe; N Nidey; J Standley; M J Schnieders; J C Murray
Journal:  J Dent Res       Date:  2017-08-21       Impact factor: 6.116

3.  Loss-of-function mutations in FGF8 can be independent risk factors for holoprosencephaly.

Authors:  Sungkook Hong; Ping Hu; Erich Roessler; Tommy Hu; Maximilian Muenke
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

4.  Syndromes associated with holoprosencephaly.

Authors:  Paul Kruszka; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-17       Impact factor: 3.908

5.  Molecular testing in holoprosencephaly.

Authors:  Paul Kruszka; Ariel F Martinez; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-17       Impact factor: 3.908

6.  BOC is a modifier gene in holoprosencephaly.

Authors:  Mingi Hong; Kshitij Srivastava; Sungjin Kim; Benjamin L Allen; Daniel J Leahy; Ping Hu; Erich Roessler; Robert S Krauss; Maximilian Muenke
Journal:  Hum Mutat       Date:  2017-07-21       Impact factor: 4.878

7.  New SHH and Known SIX3 Variants in a Series of Latin American Patients with Holoprosencephaly.

Authors:  Viviane Freitas de Castro; Daniel Mattos; Flavia Martinez de Carvalho; Denise Pontes Cavalcanti; Milagros M Duenas-Roque; Juan Llerena; Viviana Raquel Cosentino; Rachel Sayuri Honjo; Julio Cesar Loguercio Leite; Maria Teresa Sanseverino; Márcia Pereira Alves de Souza; Pricila Bernardi; Ana Maria Bolognese; Luiz Carlos Santana da Silva; Pablo Barbero; Patricia Santana Correia; Larissa Souza Mario Bueno; Clarice Pagani Savastano; Iêda Maria Orioli
Journal:  Mol Syndromol       Date:  2021-06-15

8.  Novel heterozygous mutation in the extracellular domain of FGFR1 associated with Hartsfield syndrome.

Authors:  Masaki Takagi; Tatsuya Miyoshi; Yuka Nagashima; Nao Shibata; Hiroko Yagi; Ryuji Fukuzawa; Tomonobu Hasegawa
Journal:  Hum Genome Var       Date:  2016-10-13

9.  In-depth investigations of adolescents and adults with holoprosencephaly identify unique characteristics.

Authors:  Karin Weiss; Paul Kruszka; Maria J Guillen Sacoto; Yonit A Addissie; Donald W Hadley; Casey K Hadsall; Bethany Stokes; Ping Hu; Erich Roessler; Beth Solomon; Edythe Wiggs; Audrey Thurm; Robert B Hufnagel; Wadih M Zein; Jin S Hahn; Elaine Stashinko; Eric Levey; Debbie Baldwin; Nancy J Clegg; Mauricio R Delgado; Maximilian Muenke
Journal:  Genet Med       Date:  2017-06-22       Impact factor: 8.822

10.  Cohesin complex-associated holoprosencephaly.

Authors:  Paul Kruszka; Seth I Berger; Valentina Casa; Mike R Dekker; Jenna Gaesser; Karin Weiss; Ariel F Martinez; David R Murdock; Raymond J Louie; Eloise J Prijoles; Angie W Lichty; Oebele F Brouwer; Evelien Zonneveld-Huijssoon; Mark J Stephan; Jacob Hogue; Ping Hu; Momoko Tanima-Nagai; Joshua L Everson; Chitra Prasad; Anna Cereda; Maria Iascone; Allison Schreiber; Vickie Zurcher; Nicole Corsten-Janssen; Luis Escobar; Nancy J Clegg; Mauricio R Delgado; Omkar Hajirnis; Meena Balasubramanian; Hülya Kayserili; Matthew Deardorff; Raymond A Poot; Kerstin S Wendt; Robert J Lipinski; Maximilian Muenke
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.